Neuronal-glial interactions mediated by interleukin-1 neuronal acetylcholinesterase activity and mRNA expression

Journal of Neuroscience

Volumn 20, Issue 1, 2000, Pages 149-155

  Li, Yuekui ^a   Liu, Ling ^a   Kang, Jinsong ^a,d   Sheng, Jin G ^a   Barger, Steven W ^a,b,c   Mrak, Robert E ^b,c   Griffin, W Sue T ^a,b,c,e  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^d JILIN UNIVERSITY   (China)

^e Research 151   (United States)

Author keywords

Acetylcholinesterase; Alzheimer's disease; Choline acetyltransferase; Cholinergic systems; Interleukin 1; Neuronal cultures; Neuronal stress; PC12 cells; amyloid precursor protein

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN; CHOLINE ACETYLTRANSFERASE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; MESSENGER RNA;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL INTERACTION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; GLIA; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT;

EID: 0033993523     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.20-01-00149.2000     Document Type: Article

References (51)

1. Alvarez A, Opazo C, Alarcon R, Garrido J, Inestrosa NC (1997) Acetylcholinesterase promotes the aggregation of amyloid-β-peptide fragments by forming a complex with the growing fibrils. J Mol Biol 272:348-361.
2. Atack JR, Perry EK, Bonham JR, Perry RH, Tomlinson BE, Blessed G, Fairbairn A (1983) Molecular forms of acetylcholinesterase in senile dementia of Alzheimer type: selective loss of the intermediate (10S) form. Neurosci Lett 40:199-204.
3. Barger SW, Harmon AD (1997) Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 388:878-881.
4. Barger SW, Mattson MP (1996) Induction of neuroprotective κB-dependent transcription by secreted forms of the Alzheimer's β-amyloid precursor. Mol Brain Res 40:116-126.
5. Bartus RT, Dean RL, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408-417.
6. Beeri R, Andres C, Lev-Lehman E, Timberg R, Huberman T, Shani M, Soreq H (1995) Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice. Curr Top Biol 5:1063-1071.
7. Brugg B, Dubreuil YL, Huber G, Wollman EE, Delhaye-Bouchaud N, Mariani J (1995) Inflammatory processes induce β-amyloid precursor protein changes in mouse brain. Proc Natl Acad Sci USA 92:3032-3035.
8. Buxbaum JD, Oishi M, Chen HI, Pinkas-Kramarski R, Jaffe EA, Gandy SE, Greengard P (1992) Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor. Proc Natl Acad Sci USA 89:10075-10078.
9. Corridan SB, Mauel J, Donini SD, Quattrocchi E, Ricciardi-Castagnoli P (1993) Inducible nitric oxide synthase activity of cloned murine microglial cells. Glia 7:255-262.
10. Ellman GL, Courtney KD, Andres V, Featherstone RM (1961) A new and rapid calorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 147:393-406.
11. Fonnum F (1975) A rapid radiochemical method for the determination of choline acetyltransferase. J Neurochem 24:407-409.
12. Forloni G, Demicheli F, Giorgi S, Bendotti C, Angeretti N (1992) Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1. Brain Res Mol Brain Res 16:128-134,
13. Freidin M, Kessler JA (1991) Cytokine regulation of substance P expression in sympathetic neurons. Proc Natl Acad Sci USA 88:3200-3203.
14. Froissard P, Monrocq H, Duval D (1997) Role of glutathione metabolism in the glutamate-induced programmed cell death of neuronal-like PC12 cells. Eur J Pharmacol 326:93-99.
15. Goldgaber D, Harris HW, Hla T, Maciag T, Donnelly RJ, Jacobsen JS, Vitek MP, Gajdusek DC (1989) Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc Natl Acad Sci USA 86:7606-7610.
16. Gomez-Ramos P, Mufson EJ, Moran MA (1992) Ultrastructural localization of acetylcholinesterase in neurofibrillary tangles, neuropil and senile plaques in aged and Alzheimer's brain. Brain Res 569:229-237.
17. Griffin WST, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CL III, Araoz C (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 86:7611-7615.
18. Griffin WST, Sheng JG, Roberts GW, Mrak RE (1995) Interleukin-1 expression in different plaque types in Alzheimer's disease. J Neuropath Exp Neurol 54:276-281.
19. Griffin WST, Sheng JG, Royston MC, Gentleman SM, McKenzie JE, Graham DI, Roberts GW, Mrak RE (1998) Glial-neuronal interactions in Alzheimer's disease: the potential role of a cytokine cycle in disease progression. Brain Pathol 8:65-72.
20. Hall ZW, Kelly RB (1971) Enzymatic detachment of endplate acetylcholinesterase form muscle. Nat New Biol 232:62-63.
21. Inestrosa NC, Alvarez A, Perez CA, Moreno RD, Vicente M, Linker C, Casanueva OI, Soto C, Garrido J (1996) Acetylcholinesterase accelerates assembly of amyloid-b-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. Neuron 16:881-891.
22. Jolly-Tornetta C, Gao Z, Lee VM-Y, Wolf BA (1998) Regulation of Amyloid precursor protein secretion by glutamate receptors in human Ntera 2 neurons (NT2N). J Biol Chem 273:14015-14021.
23. Kaufer D, Friedman A, Seidman S, Soreq H (1998) Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 393:373-377.
24. Layer PG, Willbold E (1995) Novel functions of cholinesterases in development, physiology and disease. Prog Histochem Cytochem 29:1-99.
25. Li Y, Wang J, Sheng JG, Liu L, Barger SW, Jones RA, Van Eldik LJ, Mrak RE, Griffin WST (1998) S100β increase levels of β-amyloid precursor protein and its encoding mRNA in rat neuronal cultures. J Neurochem 71:1421-1428.
26. Mesulam M-M (1986) Alzheimer plaques and cortical cholinergic innervation. Neuroscience 17:275-276.
27. Montz H, Koch KC, Zierz R, Gotze O (1991) The role of C5a in interleukin-6 production induced by lipopolysaccharide or interleukin-1. Immunology 74:373-379.
28. Moran MA, Mufson EJ, Gomez-Ramos P (1993) Colocalization of cholinesterases with β-amyloid protein in aged and Alzheimer's brain. Acta Neuropathol 85:362-369.
29. Mori F, Lai C, Fusi F, Giacobini E (1995) Cholinesterase inhibitors increase secretion of APPs in rat brain cortex. NeuroReport 6:633-636.
30. Muller D, Wiegmann H, Langer U, Motzen-Lenz S, Nitsch RM (1998) Lu 25-109, a combined m1 agonist and m2 antagonist, modulates regulated processing of the amyloid precursor protein of Alzheimer's disease. J Neural Transm 105:1029-1043.
31. Murphy TH, Miyamoto M, Sastre A, Schnaar RL, Coyle JT (1989) Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 2:1547-1558.
32. Murray CA, Lynch MA (1998a) Evidence that increased hippocampal expression of the cytokine interleukin-1 beta is a common trigger for age- and stress-induced impairments in long-term potentiation. J Neurosci 18:2974-2981.
33. Murray CA, Lynch MA (1998b) Dietary supplementation with vitamin E reverses the age-related deficit in long term potentiation in dentate gyrus. J Biol Chem 273:12161-12168.
34. Nitsch RM, Deng A, Wurtman RJ, Growdon JH (1997) Metabotropic glutamate receptor subtype mGluR 1 α stimulates the secretion of the amyloid beta-protein precursor ectodomain. J Neurochem 69:704-712.
35. Paciotti GF, Tamarkin L (1988) Interleukin-2 differentially affects the proliferation of a hormone-dependent and a hormone-independent human breast cancer cell line in vitro and in vivo. Anticancer Res 8:1233-1239.
36. Rogers J, Griffin WST (1997) Inflammatory mechanisms of Alzheimer's disease. In: Neurodegeneration: inflammatory mechanisms and management (Wood PL, ed), pp 177-193. Totowa, NJ: Humana.
37. Rogers JT, Leiter LM, McPhee J, Cahill CM, Zhan SS, Potter H, Nilsson LN (1999) Translation of the Alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5'-untranslated region sequences. J Biol Chem 274:6421-6431.
38. Salpeter M (1967) Electron microscope radioautography as a quantitative tool in enzyme cytochemistry. I. The distribution of acetylcholinesterase at motor endplates of a vertebrate twitch muscle. J Cell Biol 32:379-389.
39. Sberna G, Saez-Valero J, Li Q-X, Czech C, Beyreuther K, Masters CL, McLean CA, Small DH (1998) Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the β-amyloid protein precursor of Alzheimer's disease. J Neurochem 71:723-731.
40. Schneider H, Pitossi F, Balschun D, Wagner A, del Rey A, Besedovsky HO (1998) A neuromodulatory role of interleukin-1beta in the hippocampus. Proc Natl Acad Sci USA 95:7778-7783.
41. Shen ZX (1994) Acetylcholinesterase provides deeper insights into Alzheimer's disease. Med Hypoth 43:21-30.
42. Sheng JG, Mrak RE, Rovnaghi CR, Kozlowska E, Van Eldik LJ, Griffin WST (1996) Human brain S100α and S100β mRNA expression increases with age: Pathogenic implications for Alzheimer's disease. Neurobiol Aging 17:359-363.
43. Smith AD, Cuello AC (1984) Alzheimer's disease and acetylcholinesterase-containing neurons. Lancet 1:513.
44. Sternfeld M, Ming G-L, Song H-J, Sela K, Timherg R, Poo M-M, Soreq H (1998) Acetylcholinesterase enhances neunte growth and synapse development through alternative contributions of its hydrolytic capacity, core protein, and variable C termini. J Neurosci 18:1240-1249.
45. Tago H, Kimura H, Maeda T (1986) Visualization of detailed acetylcholinesterase fiber and neuron staining in rat brain by a sensitive histochemical procedure. J Histochem Cytochem 34:1431-1438.
46. Ulrich J, Meier-Ruge W, Probst A, Meier E, Ipsen S (1990) Senile plaques: staining for acetylcholinesterase and A4 protein: a comparative study in the hippocampus and entorhinal cortex. Acta Neuropathol 80:624-628.
47. Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR (1981) Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 10:122-126.
48. Willard LB, Hauss-Wegrzyniak B, Wenk GL (1999) Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats. Neuroscience 88:193-200.
49. Winkler J, Suhr ST, Gage FH, Thai LJ, Fisher LJ (1995) Essential role of acetylcholine in spatial memory. Nature 375:484-487.
50. Wright CI, Geula C, Mesulam M-M (1993) Protease inhibitors and indoleamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer disease. Proc Natl Acad Sci USA 90:683-686.
51. Younkin SG, Goodridge B, Katz J, Lockett G, Nafziger D, Usiak MF, Younkin LH (1986) Molecular forms of acetylcholinesterase in Alzheimer's disease. Fed Proc 45:2982-2988.